HIF-1 Cancer Research Results

HIF-1, HIF-1 signaling: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that plays a crucial role in cellular responses to low oxygen levels (hypoxia). It is composed of two subunits: HIF-1α and HIF-1β. Under normal oxygen conditions, HIF-1α is rapidly degraded, but in hypoxic conditions, it stabilizes, translocates to the nucleus, and dimerizes with HIF-1β to activate the transcription of various genes involved in processes such as angiogenesis, metabolism, and cell survival.
HIF-1α is often overexpressed due to the hypoxic microenvironment created by rapid tumor growth and inadequate blood supply. This upregulation allows cancer cells to adapt to low oxygen levels. HIF-1 regulates the expression of numerous target genes involved in angiogenesis (e.g., VEGF), glucose metabolism (e.g., GLUT1), cell survival, and invasion. The activation of these genes promotes tumor growth and metastasis.
However, HIF-1 is expressed in pathological conditions such as cancer and obesity.


NA, Not Available: Click to Expand ⟱
none (reserved)

Scientific Papers found: Click to Expand⟱
1416- Bos,    Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent
- Review, NA, NA
5LO↓, TumCCA↑, LC3B↓, PI3K↓, Akt↓, Glycolysis↓, AMPK↑, mTOR↓, Let-7↑, COX2↓, VEGF↓, CXCR4↓, MMP2↓, MMP9↓, HIF-1↓, angioG↓, TumCP↓, TumCMig↓, NF-kB↓,
682- EGCG,    Suppressive Effects of EGCG on Cervical Cancer
- Review, NA, NA
E7↓, E6↓, PI3K/Akt↓, P53↑, p27↑, P21↑, CDK2↓, mTOR↓, HIF-1↓, IGF-1↓, EGFR↓, ERK↓, VEGF↓,
950- EMD,    Emodin Decreases Hepatic Hypoxia-Inducible Factor-1[Formula: see text] by Inhibiting its Biosynthesis
- in-vivo, NA, NA - in-vitro, Liver, HepG2
HIF-1↓,
845- Gra,    A Review on Annona muricata and Its Anticancer Activity
- Review, NA, NA
GlucoseCon↓, ATP↓, HIF-1↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ERK↓, Akt↓, Apoptosis↑, NF-kB↓, ROS↑, Bax:Bcl2↑, MMP↓, Casp3↑, Casp9↑, p‑JNK↓,
39- QC,    A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells
- Analysis, NA, NA
ROS↑, GSH↓, IL6↓, COX2↓, IL8↓, iNOS↓, TNF-α↓, MAPK↑, ERK↑, SOD↑, ATP↓, Casp↑, PI3K/Akt↓, mTOR↓, NOTCH1↓, Bcl-2↓, BAX↑, IFN-γ↓, TumCP↓, TumCCA↑, Akt↓, P70S6K↓, *Keap1↓, *GPx↑, *Catalase↑, *HO-1↑, *NRF2↑, NRF2↑, eff↑, HIF-1↓,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↓, 1,   NRF2↑, 1,   ROS↑, 2,   SOD↑, 1,  

Mitochondria & Bioenergetics

ATP↓, 2,   MMP↓, 1,  

Core Metabolism/Glycolysis

AMPK↑, 1,   GlucoseCon↓, 1,   Glycolysis↓, 1,   HK2↓, 1,   LDHA↓, 1,   PI3K/Akt↓, 2,  

Cell Death

Akt↓, 3,   Apoptosis↑, 1,   BAX↑, 1,   Bax:Bcl2↑, 1,   Bcl-2↓, 1,   Casp↑, 1,   Casp3↑, 1,   Casp9↑, 1,   iNOS↓, 1,   p‑JNK↓, 1,   MAPK↑, 1,   p27↑, 1,  

Autophagy & Lysosomes

LC3B↓, 1,  

DNA Damage & Repair

P53↑, 1,  

Cell Cycle & Senescence

CDK2↓, 1,   P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

ERK↓, 2,   ERK↑, 1,   IGF-1↓, 1,   Let-7↑, 1,   mTOR↓, 3,   NOTCH1↓, 1,   P70S6K↓, 1,   PI3K↓, 1,  

Migration

5LO↓, 1,   MMP2↓, 1,   MMP9↓, 1,   TumCMig↓, 1,   TumCP↓, 2,  

Angiogenesis & Vasculature

angioG↓, 1,   EGFR↓, 1,   HIF-1↓, 5,   VEGF↓, 2,  

Barriers & Transport

GLUT1↓, 1,   GLUT4↓, 1,  

Immune & Inflammatory Signaling

COX2↓, 2,   CXCR4↓, 1,   IFN-γ↓, 1,   IL6↓, 1,   IL8↓, 1,   NF-kB↓, 2,   TNF-α↓, 1,  

Drug Metabolism & Resistance

eff↑, 1,  

Clinical Biomarkers

E6↓, 1,   E7↓, 1,   EGFR↓, 1,   IL6↓, 1,  
Total Targets: 60

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

Catalase↑, 1,   GPx↑, 1,   HO-1↑, 1,   Keap1↓, 1,   NRF2↑, 1,  
Total Targets: 5

Scientific Paper Hit Count for: HIF-1, HIF-1 signaling
1 Boswellia (frankincense)
1 EGCG (Epigallocatechin Gallate)
1 Emodin
1 Graviola
1 Quercetin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:0  Cells:%  prod#:%  Target#:142  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page